North America Genital Warts Market – Industry Trends and Forecast to 2028

Market Analysis and Insights: North America Genital Warts Market

 North America genital warts market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.7% in the forecast period of 2021 to 2028 and is expected to reach USD  5,263.90 million by 2028 from USD  3,218.82 million in 2020.

Genital warts are one of the most recurrent types of sexually transmitted infections. The human papillomavirus is the virus responsible for causing genital warts. People will get infected with at least one type of human papillomavirus (HPV) at some point during their lives. Genital warts affect most of the moist tissues in the genital areas of male and female patients. Although the genital infection is asymptomatic, it's frequently recognized as genital warts due to the onset of symptoms. It is estimated that around 1% of sexually active men and women in the United States have genital warts.

Genital warts are caused due to the human papillomavirus (HPV). There are around 30-40 strains of HPV. However, only a few of the strains cause genital warts. The virus is easily transmittable through skin-to-skin contact. Hence it's considered a sexually transmitted infection (STI). The Center for Disease Control and Prevention (CDC) says that people get genital warts due to the mutant activity of HPV.

The surge in prevalence of sexually transmitted diseases (STDs) and human papillomavirus infections in the U.S. rise in the male population, rise of government initiatives and awareness programs in Canada for treatment of genital warts and STDs. The rise in clinical trials, rise in healthcare expenditure and strategic initiatives by market players, and huge market potential in the U.S. and Canada bolsters the genital warts market growth.  However, the increased cost of treatment for genital warts, the side effects noticed while undergoing treatment for genital warts, and lack of patient and consumer awareness are the restraints that could hinder the market growth. The rise in product recalls associated with vaccines, and topical administration of genital warts, and patient compliance regarding the use of vaccines are the restraints that could hinder the market growth.

The North America genital warts market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological The genital warts market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

North America Genital Warts Market Scope and Market Size

• On the basis of morphology, the North Americagenital warts market is segmented into flat warts, smooth papular, cauliflower-like, and keratotic. In 2021, the cauliflower-like segment is expected to dominate the North America genital warts market due to the high prevalence of cauliflower shapes observed in male patients and ease of identification and treatment.
• On the basis of type, the North Americagenital warts market is segmented into prevention, diagnostics, and treatment. In 2021, the prevention segment is expected to dominate the North America genital warts market as the prevention is increased due to the availability of Gardasil and Cervarix vaccines and better immunity of the patients in the U.S.
• On the basis of cause, the North Americagenital warts market is segmented into HPV 6, HPV 11, and others. In 2021, the HPV 6 segment is expected to dominate the North Americagenital warts market owing to the HPV 6 strain having the highest abundance in the number of cases and have a higher prevalence rate than HPV 11.
• On the basis of location, the North America genital warts market is segmented into cervix uteri, urethra, anus, vulva, and scrotum. In 2021, the vulva segment is expected to dominate the North Americagenital warts market because the prevalence rate in women is higher than the men, and vulva have the softest tissue and secretory glands.
• On the basis of gender, the North America genital warts market is segmented into male and female. In 2021, the female segment is expected to dominate the North America genital warts market due to the higher prevalence or incidence rate in females and rise in the female population.
• On the basis of dosage, the North America genital warts market is further sub-segmented into cream, gel, ointment, intramuscularly, and others. In 2021, the cream segment is expected to dominate the North Americagenital warts market because treatment with cream is the easiest way to treat genital warts and ease of administration.
• On the basis of end-users, the North America genital warts market is segmented into hospitals, diagnostic centers, surgical centers, ambulatory surgical centers, and others. In 2021, the hospitals' segment is expected to dominate the North America genital warts market as hospitals patients have all the facilities as they can directly contact to doctors, which can diagnose the disease and take the effective treatment with the advice of doctors who are experts and rise in healthcare expenditure in the U.S.
• On the basis of distribution channels, the North America genital warts market is segmented into direct tender, pharmacy stores, and others. In 2021, the direct tender segment is expected to dominate the North Americagenital warts market as there is no requirement for the prescription of doctors and a rise in the number of wholesalers.

North America Genital Warts Market Country Level Analysis

The North America genital warts market is analyzed, and market size information is provided by the product, method, wound type, end-user.

The countries covered in the North America genital warts market report are the U.S., Canada, and Mexico.

• In 2021, U.S. is dominating due to the presence of the largest consumer market with high GDP. Moreover, the U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products, including dandruff treatment products, due to the presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

The Growth Potential For Genital Wartsin Emerging Economies And The Strategic Initiatives By Market Players Are Creating New Opportunities In The North America Genital Wartsmarket

North America genital warts market also provides you with detailed market analysis for every country growth in a particular industry with the genital warts sales, impact of advancement in genital warts, and changes in regulatory scenarios with their support for the genital warts market. The data is available for the historic period 2010 to 2019.

Competitive Landscape and North America Genital Warts Market Share Analysis

North America genital warts market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the genital warts market.

The major companies providing the genital warts are Bausch Health Companies Inc., CryoSurgery, Inc., Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc, Taro Pharmaceutical Industries Ltd, Glenmark Pharmaceutical Inc., USA (a subsidiary of Glenmark Pharmaceuticals Ltd., Edge Pharma, CryoConcepts LP, GlaxoSmithKline plc, ANI Pharmaceuticals, Inc., Verrica Pharmaceuticals, Novan, Inc, Serum Institute of India Pvt. Ltd, Fotona, Orgenesis Inc, Perrigo Company plc, among others.

DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players along with new technological advancements for North America genital warts are bridging the gap for the treatment of chronic lung diseases.

For instance,

• In June 2021,  ANI Pharmaceuticals, Inc. had presented its product portfolio at the Raymond James Human Health Innovation Conference 2021. The conference attended by the company would help the company deliver knowledge about the topical products used to treat genital warts.

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the genital warts market, which also provides the benefit for an organization to improve their offering for North America genital warts market.

SKU-64293